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Background: Hyponatremia is often observed in patients with Legionella pneumonia. However, other electrolyte
abnormalities are uncommon and the mechanism remains to be clarified.
Case presentation: We experienced two male cases of acquired Fanconi syndrome associated with Legionella
pneumonia. The laboratory findings at admission showed hypophosphatemia, hypokalemia, hypouricemia and/or
hyponatremia. In addition, they had the generalized dysfunction of the renal proximal tubules presenting decreased
tubular reabsorption of phosphate (%TRP), increased fractional excretion of potassium (FEK) and uric acid (FEUA),
low-molecular-weight proteinuria, panaminoaciduria and glycosuria. Therefore, they were diagnosed as Fanconi
syndrome. Treatment for Legionella pneumonia with antibiotics resulted in the improvement of all serum electrolyte
abnormalities and normalization of the %TRP, FEK, FEUA, low-molecular-weight proteinuria, panaminoaciduria and
glycosuria, suggesting that Legionella pneumophila infection contributed to the pathophysiology of Fanconi
syndrome.
Conclusion: To the best of our knowledge, this is the first report demonstrating Fanconi syndrome associated with
Legionella pneumonia.
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Fanconi syndrome is a generalized dysfunction of the renal
proximal tubules without primary glomerular involve-
ment. It is typically characterized by variable degrees of
phosphate, amino acids or glucose wasting by the prox-
imal tubules. In addition, hypokalemia, hypouricemia,
metabolic acidosis and low-molecular-weight proteinuria
can be part of the clinical spectrum [1]. Acquired forms of
Fanconi syndrome are caused by paraproteinemia, Sjögren
syndrome, primary biliary cirrhosis (PBC) and drugs such
as cisplatin [2-4]. However, infectious diseases have not
been reported as a cause of Fanconi syndrome.
In this report, we present extremely rare cases of
Legionella pneumonia complicated by Fanconi syndrome.* Correspondence: knstnk1984@yahoo.co.jp
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Patient 1
A 75-year-old man was admitted to our hospital with
fever and general malaise.
A physical examination at the time of admission
showed a body temperature of 38.9°C, blood pressure of
120/70 mmHg and a pulse rate of 80 beats/min. Labora-
tory findings showed a white blood cell count of 13,400/
mm3 and C-reactive protein (CRP) of 23.7 mg/dL. A chest
computed tomography (CT)-scan showed a ground-glass
appearance in the right middle and lower lobes. Because
the urinary antigen test for Legionella pneumophila sero-
type 1 (BinaxNOW® Legionella, Binax, Inc. ME, USA) was
positive, he was diagnosed as Legionella pneumonia.
Several electrolyte abnormalities coexisted including
hyponatremia, hypokalemia, hypophosphatemia and hypo-
uricemia. His renal function was normal and the arterial
blood gases analysis showed mild metabolic acidosis
(Table 1). The tubular reabsorption of phosphate (%TRP)
was decreased, although the fractional excretion of uric
acid (FEUA) was increased, indicating disturbed proximaled Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 Laboratory data on admission
Normal range Patient 1 Patient 2
BUN 8–22 mg/dL 17 41
Serum creatinine 0.71–1.20 mg/dL 0.88 2.23
Serum sodium 136–147 mEq/L 121 143
Serum potassium 3.6–5.0 mEq/L 3.4 3.5
Serum phosphorus 2.5–4.3 mg/dL 1.3 2.0
Serum uric acid < 7.0 mg/dL 2.4 2.7
Serum chloride 101–109 mEq/L 83 107
Serum CPK 56–244 IU/L 670 2,330
Bicarbonate 22.0–26.0 mEq/L 20.8 15.7
Anion gap 12 ± 2 mEq/L 15.2 20.3
Serum osmolarity 285–295 mOsm/kg 255 N.D.
Urinary osmolarity mOsm/kg 673 N.D.
ADH 0.3–4.2 pg/mL 1.7 N.D.
Proteinuria Negative; (−) (2+) (2+)
Leukocyturia Negative; (−) (−) (−)
Urinary pH 4.8–7.5 6.5 5.5
Urinary glucose Negative; (−) (3+) (2+)
Urinary RBC 0–4/HPF 10–19/HPF 10–19/HPF
%TRP 81–90% 54.0 51.0
FEK 10.0–20.0% 18.4 33.1
FEUA 5.5–11.0% 18.7 42.8
β2-MG < 250 μg/L 80,397 110,556
NAG < 7.0 U/L 18.0 19.7
Definition of the abbreviations: ADH antidiuretic hormone, BUN blood urea
nitrogen, CPK creatine phosphokinase, FEK fractional excretion of potassium, FEUA
fractional excretion of uric acid, HPF high power field, NAG N-acetyl-β-D-
glucosaminidase, N.D. not determined, RBC red blood cell, %TRP tubular
reabsorption of phosphate, WBC white blood cell, β2-MG β2-microglobulin.
Conversion factors for units: BUN in mg/dL to mmol/L, × 0.357, creatinine in mg/
dL to mmol/L, × 88.4, phosphorus in mg/dL to mmol/L, × 0.3229, uric acid in mg/
dL to μmol/L, × 59.48, and ADH in pg/mL to pmol/L, × 0.923. No conversion is
necessary for sodium, potassium, chloride, CPK, bicarbonate, anion gap, and
osmolarity.
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potassium excretion was not suppressed. Elevations in urin-
ary levels of β2-microglobulin (β2-MG) and N-acetyl-β-D-
glucosaminidase (NAG), glycosuria and panaminoaciduria
were also observed (Tables 1 and 2). Therefore, he was
diagnosed as Fanconi syndrome.
In addition, his urinary osmolarity was greater than his
serum osmolarity and the level of antidiuretic hormone
(ADH) was improperly high for the indicated serum
osmolarity. There was no sign of extracellular fluid volume
depletion. Therefore, a diagnosis of the syndrome of in-
appropriate secretion of ADH (SIADH) was also made.
He was treated for Legionella pneumonia with
pazufloxacin mesilate (PZFX) at 1,000 mg per day.
After treatment, his physical status recovered and his
electrolyte abnormalities improved. Furthermore, his %TRP,FEUA, urinary β2-MG and NAG normalized, and the
panaminoaciduria became undetectable (Figure 1A).
Patient 2
A 57-year-old man was admitted to our hospital with
fever and dysarthria.
A physical examination showed a body temperature of
39.1°C, a blood pressure of 112/48 mmHg and a pulse
rate of 98 beats/min. Laboratory findings showed a white
blood cell count of 6,100/mm3 and CRP of 46.7 mg/dL.
A chest CT scan showed a ground-glass appearance in
the left upper and lower lobes. Because of the positive
urinary antigen test, he was diagnosed as Legionella
pneumonia.
Several electrolyte abnormalities coexisted including
hypophosphatemia, hypokalemia and mild hypouricemia.
The arterial blood gas analysis showed metabolic acid-
osis (Table 1). The %TRP was decreased, although his
fractional excretion of potassium (FEK) and FEUA were
increased. Furthermore, his urinary β2-MG and NAG
were remarkably increased (Table 1). Glycosuria and
aminoaciduria were also observed (Table 2). Therefore, a
diagnosis of Fanconi syndrome was made. Although his
renal function was deteriorated, post-renal obstructive
nephropathy and congenital anomalies were ruled out by
the finding of abdominal CT scan.
Treatment for Legionella pneumonia was started with
PZFX at 1,000 mg per day. After treatment, his symptoms
disappeared and his electrolyte abnormalities improved. In
addition, his %TRP, FEK, FEUA, urinary β2-MG and NAG
normalized, and the aminoaciduria became undetectable
(Figure 1B).
Conclusions
Because the electrolyte abnormalities disappeared after
treatment for Legionella pneumonia and there was no
evidence of other causes of Fanconi syndrome, it is most
likely that Fanconi syndrome was associated with Legion-
ella pneumonia in our cases. This is the first report of
acquired Fanconi syndrome caused by infectious
diseases.
Hyponatremia is known as a relatively common elec-
trolyte abnormality in patients with Legionella pneumo-
nia [5]. The responsible mechanism of hyponatremia is
thought to be SIADH. In accordance with this mechanism,
the hyponatremia in Patient 1 was accompanied by im-
properly high levels of ADH and improved following the
recovery from Legionella pneumonia.
However, other electrolyte abnormalities are uncom-
mon in patients with Legionella pneumonia, and the
precise mechanism remains to be clarified [5]. In our
cases, the laboratory findings at admission also showed
hypophosphatemia, hypokalemia and hypouricemia. In
addition, remarkably increased urinary excretion of low-
Table 2 Data of the analysis of urinary amino acids on admission
Normal range (mmol/day) Patient 1 Patient 2
Taurine 322.2–5214.5 1318.6 272.5
Phosphoethanolamine 31.0–110.0 49 34.4
Urea 130.3–493.2 223.9 341.3
Aspartic acid < 12.7 N.D. 6.1
Hydroxyproline N.D. N.D. N.D.
Threonine 79.9–528.3 1530.2 380.7
Serine 208.8–1020.0 1529.6 478.3
Asparagine 60.7–372.3 747.4 393.6
Glutamic acid 11.3–42.7 30.1 15.5
Glutamine 207.0–1357.3 1071.2 170.3
Sarcosine < 99.0 24.8 N.D.
α-Aminoadipic acid 16.7–118.6 52.4 34.4
Proline N.D. 18.4 25.6
Glycine 652.1–3670.6 852.4 336.2
Alanine 141.2–833.9 839.3 538.6
Citrulline 13.5–55.6 63.4 N.D.
α-Aminobutylic acid < 27.1 N.D. N.D.
Valine 24.8–82.2 97 104.2
Cystine 23.7–170.9 226.2 101.3
Cystathionine < 44.7 21 334.6
Methionine < 20.2 11.5 15.5
Isoleucine 7.5–23.5 26.5 29.2
Leucine 24.6–89.3 95.5 96.3
Tyrosine 50.6–308.4 327.4 111.8
Phenylalanine 27.2–110.2 150.7 199.8
γ-Amino β-hydroxybutyric acid N.D. N.D. N.D.
β-Alanine < 153.0 58.4 9.4
β-Amino-iso-butyric acid < 1623.9 151.8 288.5
γ-Aminobutyric acid N.D. N.D. N.D.
Monoethanolamine 195.3–606.2 292.8 356.8
Homocystine N.D. N.D. N.D.
Histidine 436.4–2786.5 1392 496.8
3-Methylhistidine 113.4–480.9 202.9 396
1-Methylhistidine 59.3–2816.2 821.2 16.7
Carnosine < 87.6 N.D. 21.2
Anserine < 231.4 49.4 N.D.
Tryptophan 20.7–150.7 156.7 59.2
Hydroxylysine < 22.9 3.8 N.D.
Ornithine 6.9–43.9 46.3 151.4
Lysine 51.6–1639.6 794.9 148.1
Arginine 11.6–54.8 51.5 31.3
Underlining indicates an abnormal value.
N.D. means not detected.
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Figure 1 Clinical course in Patient 1 (A) and Patient 2 (B). Definition of the abbreviations: CRP = C-reactive protein, eGFR = estimated glomerular
filtration rate, FEUA = fractional excretion of uric acid, GRNX= garenoxacin mesilate hydrate, LVFX = levofloxacin hydrate, Pi = phosphate (inorganic),
PZFX = pazufloxacin mesilate, S-Sodium= serum sodium, UA = uric acid, U-β2-MG= urinary β2-microglobulin, %TRP = tubular reabsorption
of phosphate.
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%TRP, increased FEK and FEUA, panaminoaciduria and
glycosuria were coexisted. Therefore, our cases suggest
that the proximal tubular dysfunction caused these serum
electrolyte abnormalities.
A relationship has recently been proposed between
mitochondrial disorders and Fanconi syndrome [6,7]. For
instance, it is known that patients with mitochondrial
disorders, including mitochondrial encephalomyopathy,lactic acidosis, and stroke-like episodes (MELAS), Kearns-
Sayre syndrome, and anti-mitochondrial M2 antibody-
positive primary biliary cirrhosis (PBC), often complicate
with Fanconi syndrome [4,8,9]. Moreover, Fanconi syn-
drome related to antiviral agents, such as cidofovir, is
thought to be caused by mitochondrial toxicity [10]. Be-
cause the mitochondria play a critical role in generating
adenosine triphosphate (ATP) through oxidative phos-
phorylation and tubular epithelial cells, particularly in the
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from the mitochondria, it is reasonable that mitochon-
drial disorders can cause Fanconi syndrome. Interest-
ingly, Evans et al. have reported that Legionella
pneumophila, which is a facultative intracellular bacter-
ium, was found inside renal tubular cells in autopsy
cases of Legionella pneumonia [11]. In addition, it has
been reported that Legionella pneumophila infection af-
fects mitochondrial functions in mammalian cells [12,13].
Therefore, Legionella pneumophila infected the proximal
tubular cells might interfere with their mitochondria and
finally cause Fanconi syndrome in our cases.
However, we cannot explain the following issues: (i)
from where Legionella pneumophila entered inside the
renal proximal tubular cells (from basolateral or apical)
and (ii) why the reabsorption defects developed only in
the proximal tubules, not in the distal tubules. Further-
more, we cannot rule out the possibility that acute
tubulointerstitial nephritis was occurred in the setting of
Legionella pneumonia [14], although this possibility
should be low because of the absence of typical symp-
toms such as rash and leukocyturia in our cases.
In summary, we experienced two rare cases of Legionella
pneumonia complicated with Fanconi syndrome. Fur-
ther studies are required to clarify the precise mecha-
nisms responsible for the association between Legionella
pneumophila infection and Fanconi syndrome.
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